Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Girish S. Kulkarni is a leading urologic oncologist whose research centers on optimizing surgical outcomes for bladder and prostate cancers, with a particular focus on comparing robotic and open surgical approaches. His major contributions lie in synthesizing complex clinical data through systematic reviews and meta-analyses to guide evidence-based surgical decision-making. Notably, his 2023 work on robotic versus open cystectomy for bladder cancer (9 citations) provides crucial synthesized evidence for this debated procedure, while his 2015 study on health-related quality of life in robotic versus open radical prostatectomy (9 citations) addresses the critical patient-centered question of whether robotic surgery offers meaningful functional advantages. Dr. Kulkarni further advanced the field with his 2022 network meta-analysis (4 citations) comparing open and robot-assisted radical cystectomy with different urinary diversion techniques, offering nuanced insights into complication profiles. His work has been instrumental in clarifying the comparative effectiveness of minimally invasive versus traditional open surgery, helping surgeons and patients make more informed treatment decisions. Through rigorous methodological approaches and clinically relevant outcomes analysis, Dr. Kulkarni continues to shape the landscape of urologic oncology practice.